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Functional association of CTCF with the insulator upstream of the
H19 gene is parent of origin-specific and methylation-sensitive
Chandrasekhar Kanduri*, Vinod Pant*, Dmitri Loukinov†, Elena Pugacheva†,
Chen-Feng Qi†, Alan Wolffe‡, Rolf Ohlsson* and Victor V. Lobanenkov‡
In mammals, a subset of genes inherit gametic marks
that establish parent of origin-dependent expression
patterns in the soma ([1] and references therein). The
currently most extensively studied examples of this
phenomenon, termed genomic imprinting, are the
physically linked Igf2 (insulin-like growth factor II) and
H19 genes, which are expressed mono-allelically from
opposite parental alleles [1,2]. The repressed status of
the maternal Igf2 allele is due to cis elements that
prevent the H19 enhancers [3] from accessing the Igf2
promoters on the maternal chromosome [4,5].
A differentially methylated domain (DMD) in the 5¢ flank
of H19 is maintained paternally methylated and
maternally unmethylated [6,7]. We show here by gel-shift
and chromatin immunopurification analyses that binding
of the highly conserved multivalent factor CTCF ([8,9] and
references therein) to the H19 DMD is methylation-
sensitive and parent of origin-dependent. Selectively
mutating CTCF-contacting nucleotides, which were
identified by methylation interference within the extended
binding sites initially revealed by nuclease footprinting,
abrogated the H19 DMD enhancer-blocking property.
These observations suggest that molecular mechanisms
of genomic imprinting may use an unusual ability of CTCF
to interact with a diverse spectrum of variant target sites,
some of which include CpGs that are responsible for
methylation-sensitive CTCF binding in vitro and in vivo.
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Results and discussion
The chromatin conformation of the H19 DMD displays
prominent nuclease-hypersensitive sites (NHSSs) at the
21 bp repeat conserved in mammals ([5] and references
therein). The repeat consensus has some sequence simi-
larity to the CTCF protein target sequences ([9] and refer-
ences therein). The highly conserved and ubiquitously
expressed CTCF protein has 11 Zn-fingers (ZFs). It is an
unusual multivalent factor capable of binding to remark-
ably different and ~50–60 bp long CTS sequences by uti-
lizing different sets of ZFs ([8,9] and references therein).
CTSs mediate promoter repression or activation and help
to create hormone-responsive silencers ([8,9] and refer-
ences therein). In addition, core sequences of a number of
diverse chromatin insulators in vertebrates have been nar-
rowed down to CTSs [10]. 
Figure 1
Systematic screening of the H19 DMD for CTCF-binding sites.
(a) Schematic map of the mouse Igf2–H19 genomic region with
functionally relevant regulatory elements and arrangement of
consecutive, overlapping DNA fragments, which were each labeled at
the 5¢ end. Arrows indicate the activation of each promoter by the H19
enhancers. Numbering is relative to the +1 H19 transcription start.
(b) Gel-shift assays with the DMD1 to DMD10 DNA fragments and the
11 ZF domain of CTCF synthesized from the pCITE4a-11ZF vector
[9]. Lanes 1, 2, and 3 on each panel correspond to gel-shift reactions
with no protein, with the negative luciferase protein control, and with
CTCF, respectively. Fragments producing shifted complexes (indicated
by arrows) are in red.
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To test for a link between CTCF and the H19 DMD
function, we focused on the second two thirds of the H19
DMD where we could persistently document presence of
the NHSSs upstream of NHSS I in mouse fetal liver [5].
We carried out systematic electrophoretic mobility shift
assays (EMSA) for CTSs in this H19 region and detected
two new CTSs, termed DMD4 and DMD7 (Figure 1). To
define exactly which sequences are occupied by CTCF,
and to identify guanines within these sequences that
cannot be modified without losing CTCF binding, we
performed DNase I footprinting and methylation interfer-
ence assays. The results of these experiments, shown in
Figure 2, led us to the following conclusions: first, the
positions of the DMD4 and DMD7 CTSs correspond pre-
cisely to NHSS I and NHSS II, respectively; second, in
each recognition sequence, CTCF protects ~60 bp of both
DNA strands from nuclease attack; third, inside of each
DMD CTS, CTCF induces DNase-hypersensitivity sub-
sites on the top GC-rich strand; and fourth, in both DMD4
and DMD7 CTSs, the identical CGCG(T/G)GGTG-
GCAG core motif provides major contact bases for recog-
nition by CTCF. DMD4 and DMD7 core CTSs contain
three and two CpG pairs, respectively, which are methy-
lated in vivo when derived from father [6,7]. Although the
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Figure 2
Characterization of the DMD4 and DMD7
CTCF-binding sequences. (a) DNase I
footprinting and (b) DMS-methylation
interference assays were carried out with full-
length CTCF. G, the Maxam–Gilbert
sequencing G-ladders; F and B, free and
CTCF-bound DNA probes, respectively; FP,
footprint regions protected from nuclease
attack; HS, DNase I hypersensitive sites
induced upon CTCF binding. In (b), guanines
that cannot be modified by DMS without
losing contact with CTCF are indicated by
green bars. (c) Summary of the results shown
in (a,b). Critical contact G residues are
indicated by filled rectangles; on each strand,
DNA sequences protected by CTCF from
DNase1 are underlined or overlined. The CpG
pairs (BstUI sites) that include dGs critical for
CTCF recognition are indicated by angle
brackets. (d) The CTCF chromatin map of the
maternally derived H19 DMD allele. Red
rectangles depict estimated nucleosome
positions, whereas the vertical bars identify
CpG dinucleotides [5]. The 21 bp conserved
repeats are indicated by yellow boxes, and
CTCF-produced DNase I footprints are shown
by green boxes. The numbers indicate
nucleotide positions relative to the +1
transcriptional start site of the H19 gene.
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DMD4 and DMD7 CTSs are similar one to another, they
are different from several other previously identified
CTSs [8–10], suggesting a unique contribution of interact-
ing ZFs. Indeed, EMSAs with the proteins containing 12
serial truncations from either end of the 11 ZF domain [9]
fully supported this idea (see Supplementary material).
To test whether methylation might interfere with CTCF
binding, we modified DMD4 and DMD7 CTS fragments
with the SssI methylase and compared them with the
unmodified CTS for CTCF binding. Our EMSAs
revealed a marked preference of CTCF for the unmethy-
lated DMD sites (Figure 3). We also quantitatively esti-
mated the effect of CpG methylation on the affinity of
CTCF binding to each DMD CTS by surface plasmon
resonance using the BIACORE X device. It appeared,
quite unexpectedly, that the best-fit model for CTCF-
DNA interaction is the two-stage reaction, with an inter-
mediate conformational change resulting in formation of
stable non-dissociating complexes with an apparent affin-
ity constant in the range of 1011 to 1013 M–1. In contrast,
CTCF binding to the methylated DMD4 and DMD7
sites was at least a 1,000-fold lower in affinity (~108 M–1),
and no stable complexes with methylated probes were
detected (data not shown). CTCF affinity to methylated
DMDs was still high enough to detect some residual
binding by EMSAs not designed to measure the on-and-
off binding rates (see Supplementary material).
To determine whether the H19 DMD CTS sequences
display the chromatin-insulator-like activity, we generated
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Figure 3
CTCF binding to H19 DMD is methylation-sensitive. (a) 5¢-end-labeled
control and SssI methylase-treated DMD4 and DMD7 fragments were
digested with methylation-sensitive BstUI and analyzed on polyacrylamide
gels to verify efficiency of in vitro methylation. (b,c) Control unmethylated
(cont) or SssI-methylated DMD4 and DMD7 DNA fragments were
analyzed by gel-shift assays with increasing amounts of CTCF as
indicated at the top of each panel. F, free probe; B, CTCF-bound probe. 
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Figure 4
The CTSs in H19 DMD mediate the
enhancer-blocking properties of the H19 5¢
flank. (a) EMSA shows that point mutations
within the DMD (see text and diagram below)
destroy the CTCF recognition elements. F,
free probe; B, bound probe; control is
luciferase. (b) Enhancer-blocking assay in
JEG-3 cells to assess effects of targeted
mutations in the CTSs. The assay determines
the ability of the wild-type or mutant H19
DMD to prevent the SV40 enhancer from
communicating with the promoter of the H19
reporter gene (see diagram below). GAP,
glyceraldehyde 3-phosphate dehydrogenase.
(c) Quantitation of enhancer-blocking assay
normalized to DNA input and episome copy
number. The SV40 enhancer-driven
expression of the pREPH19A construct was,
for convenience, assigned a value of 100
while all other samples were normalized
relative to this value. The mean deviation of at
least three different experiments is indicated
for each vector construct, unless the
differences were too insignificant to show.
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point mutations that eliminate CTCF interaction with the
DMD4 and DMD7 sites. Figure 4a shows that changing
the sequence GTGG to ATAT in either of the DMD
CTSs (see Figure 2c) destroyed their interaction with
CTCF. Next, we addressed whether the enhancer-block-
ing properties of the H19 DMD depend on the CTSs in
an episomal-based assay [5]. As could be expected, the tar-
geted disruption of CTCF-DMD interaction at both CTS
counteracted most of the enhancer-blocking properties of
the H19 5¢ flank (Figure 4b,c).
To examine an in vivo link between CTCF and the H19 5¢
flank, we analyzed the distribution of CTCF in formalde-
hyde-crosslinked chromatin of fetal livers of reciprocal
M. musculus musculus (M) ´ M. musculus domesticus (D)
intraspecific hybrid crosses (see Figure 5 legend). CTCF-
immunoprecipitated DNA was analyzed by a PCR assay,
which allowed the discrimination of the parental alleles of
the H19 5¢ flank by exploiting a polymorphic restriction
site, BsmAI [5]. Figure 5 shows that only the maternally
inherited allele (the M allele in the M ´ D cross) is specifi-
cally captured by the CTCF antibody. When the opposite
cross (D ´ M) was examined, the D allele was preferen-
tially amplified. Given that the average length of the soni-
cated DNA fragments was 2–3 kb, most if not all of the
potential CTCF-binding sites scattered within the DMD
of the H19 5¢ flank are likely to be covered in this assay.
We conclude that the CTCF interaction with the H19 5¢
flank is parent of origin-specific.
We have shown here that CTCF is both structurally and
functionally an integral part of the H19 DMD chromatin
conformation and that its parent of origin-dependent inter-
action with the H19 insulator is likely to involve its ability
to read the methylation mark. It is tempting to speculate
that function of CTCF as a candidate tumor suppressor
gene at chromosome segment 16q22.1, where the pre-
dicted third Wilms’ tumor gene (WT3) is localized, and
frequent loss of Igf2/H19 imprinting in these tumors ([8]
and references therein) may be causally linked. Although
our data implicate CTCF in manifesting the repressed
status of the maternal Igf2 allele in the soma, this remains
to be demonstrated in targeted deletion mouse models.
Supplementary material
Supplementary material including figures showing the combinations of
ZFs required to bind different DMDs and the methylation-sensitivity of
CTCF binding to DMDs, and additional discussion and methodological
details, is available at http://current-biology.com/supmat/supmatin.htm.
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Figure 5
Parent of origin-specific association of CTCF with the chromatin of the
H19 5¢ flank. Formaldehyde-cross-linked DNA, which was derived from
fetal liver of reciprocal intraspecific hybrid crosses of M. m. domesticus
(D) and M. m. musculus (M), was immunopurified with an antibody
to CTCF followed by PCR amplificaton. The PCR primers spanned
a polymorphic BsmAI site which was specific for the M allele. The M ´ D
or D ´ M crosses are indicated in the order mother–father in all instances.
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